John Renger, Chief Scientific Officer at Cerevel Therapeutics Holdings, Inc. (CERE), sold 37,700 shares at $32.50 ($1.2M) on 2021-12-17, disclosed to the SEC on 2021-12-17.
Open-market sale of $1.2M CERE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.02 | 25,000 | $751K | 64.5% |
| 2 | $32.50 | 5,578 | $181K | 15.6% |
| 3 | $32.50 | 7,122 | $231K | 19.9% |
| Total | $30.86 avg | 37,700 | $1.2M | 100% |
| Filing → |
| CERE | SELL | 2022-10-06 | $750K | — | Filing → |
| CERE | SELL | 2022-08-12 | $4.5M | — | Filing → |
| CERE | SELL | 2022-08-09 | $1.0M | — | Filing → |